Overview

Comparing the Efficacy of 14-day Reverse Hybrid Therapy and 14-day Triple Therapy Plus Bismuth Therapy

Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
Reverse hybrid therapy achieves a higher eradication rate than bismuth (triple therapy plus bismuth) remains unanswered
Phase:
N/A
Details
Lead Sponsor:
Kaohsiung Veterans General Hospital.
Treatments:
Amoxicillin
Bismuth
Bismuth tripotassium dicitrate
Clarithromycin
Metronidazole
Pantoprazole